Beta-interferon treatment reduces human herpesvirus-6 viral load in multiple sclerosis relapses but not in remission

European Neurology

Volumn 52, Issue 2, 2004, Pages 87-91

  Álvarez Lafuente, Roberto ^a   De Las Heras, Virginia ^a   Bartolomé, Manuel ^a   Picazo, Juan José ^a   Arroyo, Rafael ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Beta interferon; Human herpesvirus 6; Multiple sclerosis; Real time quantitative polymerase chain reaction

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE; VIRUS DNA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN HERPESVIRUS 6; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRAL GENETICS; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; DNA, VIRAL; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRAL LOAD;

EID: 4644303317     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079936     Document Type: Article

References (30)

1. Galetta SL: The controlled high risk Avonex multiple sclerosis trial (CHAMPS Study). J Neuroophthalmol 2001;21:292-295.
2. Richert ND, Ostuni JL, Bash CN, Leist TP, McFarland HF, Frank JA: Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis. Mult Scler 2001;7:49-58.
3. Dubois BD, Keenan E, Porter BE, Kapoor R, Rudge P, Thompson AJ, Miller DH, Giovannoni G: Interferon beta in multiple sclerosis: Experience in a British specialist multiple sclerosis centre. J Neurol Neurosurg Psychiatry 2003;74:946-949.
4. Fernández O, Arbizu T, Izquierdo G, Martínez-Yelamos A, Gata JM, Luque G, de Ramón E: Clinical benefits of interferon beta-1a in relapsing-remitting MS: A phase IV study. Acta Neurol Scand 2003;107:7-11.
5. Tejada-Simon MV, Zang YCQ, Hong J, Rivera VM, Zhang JZ: Cross-reactivity with myelin basic protein and human-herpesvirus-6 in multiple sclerosis. Ann Neurol 2003;53:189-197.
6. Ablashi DV, Eastman HB, Owen CB, et al: Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000;16:179-191.
7. Ablashi DV, Lapps W, Kaplan M, Whitman JE, Richert JR, Pearson GR: Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: A preliminary report. Mult Scler 1998;4:490-496.
8. Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, McFarland HF, Jacobson S: Tissue distribution and variant characterization of human herpesvirus (HHV)-6: Increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 2000;182:1321-1325.
9. Alvarez-Lafuente R, Martin-Estefania C, de las Heras V, et al: Prevalence of herpesvirus DNA in MS patients and healthy blood donnors. Acta Neurol Scand 2002;105:95-99.
10. Álvarez-Lafuente R, Martín-Estefanía C, de las Heras V, Castrillo C, Picazo JJ, Varela de Seijas E, Arroyo R: Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch Neurol 2002;59:929-933.
11. Berti R, Brennan MB, Soldan SS, et al: Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol 2002;8:250-256.
12. Cermelli C, Berti R, Soldan SS, et al: High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 2003;187:1377-1387.
13. Challoner PB, Smith KT, Parker JD, et al: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995;92:7440-7444.
14. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M: Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol 2003;69:111-117.
15. Friedman JE, Lyons MJ, Cu G, et al: The association of the human herpesvirus-6 and MS. Mult Scler 1999;5:355-362.
16. Goodman AD, Mock DJ, Powers JM, Baker JV, Blumberg BM: Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. J Infect Dis 2003;187:1365-1376.
17. Kim JS, Lee KS, Park JH, Kim MY, Shin WS: Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients. Eur Neurol 2000;43:170-173.
18. Knox KK, Brewer JH, Henry JM, Harrington DJ, Carrigan DR: Human herpesvirus 6 and multiple sclerosis: Systemic active infections in patients with early disease. Clin Infect Dis 2000;31:894-903.
19. Luttichau HR, Clark-Lewis I, Jensen PO, Moser C, Gerstoft J, Schwartz TW: A highly selective CCR2 chemokine agonist encoded by human herpesvirus 6. J Biol Chem 2003;278:10928-10933.
20. Rotola A, Cassai E, Tola MR, Granieri E, Di Luca D: Human herpesvirus 6 is latent in peripheral blood of patients with relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;67:529-531.
21. Soldan SS, Berti R, Salem N, et al: Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997;3:1394-1397.
22. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S: Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 2000;47:306-313.
23. Soldan SS, Fogdell-Hahn A, Brennan MB, et al: Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 2001;50:486-493.
24. Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ: Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol 2002;76:6147-6154.
25. Tomsone V, Logina I, Millers A, Chapenko S, Kozireva S, Murovska M: Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system. J Neurovirol 2001;7:564-569.
26. Nitsche A, Müller CW, Radonic A, Landt O, Ellerbrok H, Pauli G, Siegert W: Human Herpesvirus 6A DNA is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation. J Infect Dis 2001;183:130-133.
27. Wagner HJ, Wessel M, Jabs W, Smets F, Fischer L, Offner G, Bucsky P: Patients and risk for development of posttransplant lymphoproliferative disorder: Plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time polymerase chain reaction. Transplantation 2001;72:1012-1019.
28. Hong J, Tejada-Simon MV, Rivera VM, Zang YC, Zhang JZ: Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler 2002;8:237-242.
29. Bech E, Lycke J, Gadeberg P, Hansen HJ, Malmestrom C, Andersen O, Christensen T, Ekholm S, Haahr S, Hollsberg P, Bergstrom T, Svennerholm B, Jakobsen J: A randomised, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology 2002;58:31-36.
30. Goodman AD, Miller DH: Infections and MS: Clinical trials move to center stage. Neurology 2002;58:7-8.